• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病住院患儿艰难梭菌感染的医疗负担。

Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease.

机构信息

Section of Gastroenterology & Nutrition, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

出版信息

Inflamm Bowel Dis. 2013 Apr;19(5):1080-5. doi: 10.1097/MIB.0b013e3182807563.

DOI:10.1097/MIB.0b013e3182807563
PMID:23478808
Abstract

BACKGROUND

Children with inflammatory bowel disease (IBD), similar to adults, are at increased risk of acquiring a Clostridium difficile infection (CDI). Our objective was to characterize the health care burden associated with CDI in hospitalized pediatric patients with IBD.

METHODS

We extracted and analyzed cases with a discharge diagnosis of IBD or CDI from the U.S. Healthcare Cost and Utilization Project Kids' Inpatient Database.

RESULTS

In our primary analysis, we evaluated pediatric cases with a principal diagnosis of IBD or CDI. For the year 2009, we identified 12,610 weighted cases with IBD of which 3.5% had CDI. In children with IBD, CDI was independently associated with lengthier hospital stays (8.0 versus 6.0 days; adjusted regression coefficient, 2.1 days; 95% confidence interval [CI], 1.4-2.8), higher charges ($45,126 versus $34,703; adjusted regression coefficient, $11,506; 95% CI, 6192-16,820), and greater need for parenteral nutrition (15.9% versus 12.1%; adjusted odds ratio, 1.5; 95% CI, 1.1-2.0) and blood transfusion (17.7% versus 9.8%; adjusted odds ratio, 1.8; 95% CI, 1.4-2.4). There were no deaths. We made similar observations in a subanalysis of cases with principal or secondary diagnoses of IBD or CDI. The incidence of CDI in patients with IBD increased between 2000 and 2009 from 21.7 to 28.0 cases per 1000 IBD cases per year (P < 0.001). There was a significant increase in CDI complicating ulcerative colitis (28.1 versus 42.2, P < 0.001) but not for Crohn's disease (18.3 versus 20.3).

CONCLUSIONS

CDI represents a significant health care burden in hospitalized children with IBD.

摘要

背景

与成年人相似,患有炎症性肠病(IBD)的儿童感染艰难梭菌(CDI)的风险增加。我们的目标是描述与住院患有 IBD 的儿科患者的 CDI 相关的医疗保健负担。

方法

我们从美国医疗保健成本和利用项目儿童住院数据库中提取并分析了以 IBD 或 CDI 为主要诊断的病例。

结果

在我们的主要分析中,我们评估了主要诊断为 IBD 或 CDI 的儿科病例。在 2009 年,我们确定了 12610 例加权 IBD 病例,其中 3.5%患有 CDI。在患有 IBD 的儿童中,CDI 与住院时间延长独立相关(8.0 天与 6.0 天;调整后的回归系数为 2.1 天;95%置信区间[CI]为 1.4-2.8),费用更高(45126 美元与 34703 美元;调整后的回归系数为 11506 美元;95%CI 为 6192-16820 美元),需要更多的肠外营养(15.9%与 12.1%;调整后的优势比为 1.5;95%CI 为 1.1-2.0)和输血(17.7%与 9.8%;调整后的优势比为 1.8;95%CI 为 1.4-2.4)。没有死亡。在以 IBD 的主要或次要诊断为病例的子分析中,我们也有类似的观察结果。2000 年至 2009 年期间,IBD 患者中 CDI 的发病率从每年每 1000 例 IBD 病例 21.7 例增加到 28.0 例(P < 0.001)。溃疡性结肠炎并发 CDI 的发生率显著增加(28.1 例与 42.2 例,P < 0.001),但克罗恩病并无增加(18.3 例与 20.3 例)。

结论

CDI 代表住院患有 IBD 的儿童的重大医疗保健负担。

相似文献

1
Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease.炎症性肠病住院患儿艰难梭菌感染的医疗负担。
Inflamm Bowel Dis. 2013 Apr;19(5):1080-5. doi: 10.1097/MIB.0b013e3182807563.
2
Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors.新诊断为炎症性肠病的儿科患者中艰难梭菌感染:患病率和危险因素。
Inflamm Bowel Dis. 2012 May;18(5):844-8. doi: 10.1002/ibd.21837. Epub 2011 Sep 20.
3
Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.炎症性肠病患者中与艰难梭菌感染相关的疾病结局的时间趋势。
Inflamm Bowel Dis. 2011 Apr;17(4):976-83. doi: 10.1002/ibd.21457. Epub 2010 Sep 7.
4
Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.住院炎症性肠病合并艰难梭菌感染患者的静脉血栓栓塞发生率增加。
Inflamm Bowel Dis. 2017 Oct;23(10):1847-1852. doi: 10.1097/MIB.0000000000001218.
5
National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database.儿童炎症性肠病住院的国家负担:来自 2006 年儿童住院数据库的结果。
J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):477-85. doi: 10.1097/MPG.0b013e318239bc79.
6
Clostridium difficile infection in hospitalized children in the United States.美国住院儿童的艰难梭菌感染
Arch Pediatr Adolesc Med. 2011 May;165(5):451-7. doi: 10.1001/archpediatrics.2010.282. Epub 2011 Jan 3.
7
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.一项关于住院炎症性肠病患者艰难梭菌感染的患病率及影响的全国性调查。
Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29.
8
High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.住院炎症性肠病患者中产艰难梭菌感染的发病率和发病率高:一项前瞻性观察性队列研究。
J Dig Dis. 2019 Sep;20(9):460-466. doi: 10.1111/1751-2980.12798.
9
The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.艰难梭菌感染在儿科和成人炎症性肠病患者中的流行情况。
Dig Dis Sci. 2014 Sep;59(9):2222-7. doi: 10.1007/s10620-014-3169-4. Epub 2014 May 1.
10
Attributable Cost of Clostridium difficile Infection in Pediatric Patients.艰难梭菌感染患儿的归因成本。
Infect Control Hosp Epidemiol. 2017 Dec;38(12):1472-1477. doi: 10.1017/ice.2017.240. Epub 2017 Nov 27.

引用本文的文献

1
Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study.粪便微生物群移植治疗炎症性肠病患者与非炎症性肠病患者难治性或复发性感染的疗效比较:一项回顾性队列研究
Biomedicines. 2024 Jun 23;12(7):1396. doi: 10.3390/biomedicines12071396.
2
A Multifaced Aspect of Infection in Pediatric Patients with Inflammatory Bowel Disease: Case Series and Literature Review.炎症性肠病患儿感染的多方面情况:病例系列及文献综述
J Pers Med. 2023 Sep 20;13(9):1413. doi: 10.3390/jpm13091413.
3
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
艰难梭菌感染与儿科炎症性肠病。
Curr Gastroenterol Rep. 2023 Nov;25(11):316-322. doi: 10.1007/s11894-023-00890-9. Epub 2023 Aug 30.
4
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).接受抗菌治疗的艰难梭菌感染患儿中贝洛妥珠单抗的双盲、安慰剂对照研究(MODIFY III)。
J Pediatric Infect Dis Soc. 2023 Jun 30;12(6):334-341. doi: 10.1093/jpids/piad031.
5
Bacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms.与人类炎症性肠病相关的细菌种类及其致病机制。
Front Microbiol. 2022 Feb 24;13:801892. doi: 10.3389/fmicb.2022.801892. eCollection 2022.
6
Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.儿童和青少年炎症性肠病患者艰难梭菌感染的危险因素:系统评价和荟萃分析。
World J Pediatr. 2022 Jan;18(1):27-36. doi: 10.1007/s12519-021-00486-1. Epub 2021 Nov 20.
7
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南:成人和儿童艰难梭菌感染:美国传染病学会(IDSA)和美国医疗保健流行病学学会(SHEA) 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.
8
Infection at Diagnosis and during the Disease Course of Pediatric Inflammatory Bowel Disease.儿童炎症性肠病诊断时及病程中的感染
Pediatr Gastroenterol Hepatol Nutr. 2018 Jan;21(1):43-50. doi: 10.5223/pghn.2018.21.1.43. Epub 2018 Jan 12.
9
The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease.炎症性肠病儿科患者的医院再入院负担
J Pediatr. 2017 Dec;191:184-189.e1. doi: 10.1016/j.jpeds.2017.08.042. Epub 2017 Oct 14.
10
Management of inflammatory bowel disease with infection.炎症性肠病合并感染的管理
World J Gastroenterol. 2017 Jul 21;23(27):4986-5003. doi: 10.3748/wjg.v23.i27.4986.